Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808553092> ?p ?o ?g. }
- W2808553092 endingPage "486" @default.
- W2808553092 startingPage "482" @default.
- W2808553092 abstract "Introduction Neoadjuvant chemotherapy prior to lumpectomy or mastectomy for breast cancer challenges wound healing. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, has been shown to work synergistically with paclitaxel in vitro and in preclinical studies. In addition, our laboratory has demonstrated that SAHA treatment decreases paclitaxel-associated stem cell toxicity, modulates inflammatory response, and promotes wound healing in injured fibroblast cells. Our goal was to determine if combined SAHA and paclitaxel treatment would improve wound healing in an in vivo full-thickness murine model, without altering antitumor effect. Methods Thirty-two nude athymic mice received intraperitoneal injections of paclitaxel (20 mg/kg), SAHA (25 mg/kg), paclitaxel + SAHA (20 mg/kg + 25 mg/kg), or no treatment for 2 weeks prior to surgery. Under general anesthesia, 8-mm full-thickness dorsal wounds were created in all animals, and a silicone splint was attached to minimize wound contraction. The wounds were measured twice a week with a surgical caliper until healing was complete. To evaluate the in vivo effect of drug treatment, 16 athymic nude mice with MDA-MB-231 xenografts received the treatments described previously, following which tumor volumes were compared between groups. Results Average wound healing time was prolonged in mice treated with paclitaxel (20 ± 1.9 days), and combination SAHA + paclitaxel therapy improved average wound healing time (17.0 ± 1.8 days). In the xenograft model, the antitumor effect of SAHA and paclitaxel (average tumor volume 43.9 ± 34.1 mm3) was greater than paclitaxel alone (105.8 ± 73.8 mm3). Conclusions The addition of SAHA to taxane chemotherapy improves the therapeutic effect on triple-negative breast cancer while decreasing the detrimental effect of paclitaxel on wound healing. This may have substantial implications on improving outcomes in breast reconstruction following chemotherapy." @default.
- W2808553092 created "2018-06-21" @default.
- W2808553092 creator A5005889866 @default.
- W2808553092 creator A5009734430 @default.
- W2808553092 creator A5021383531 @default.
- W2808553092 creator A5023070517 @default.
- W2808553092 creator A5027001679 @default.
- W2808553092 creator A5040751092 @default.
- W2808553092 creator A5049109639 @default.
- W2808553092 creator A5051941269 @default.
- W2808553092 creator A5055151897 @default.
- W2808553092 creator A5064198617 @default.
- W2808553092 creator A5072032369 @default.
- W2808553092 date "2018-10-01" @default.
- W2808553092 modified "2023-10-13" @default.
- W2808553092 title "The Effect of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Paclitaxel Treatment on Full-Thickness Wound Healing in Mice" @default.
- W2808553092 cites W1835871681 @default.
- W2808553092 cites W1969356358 @default.
- W2808553092 cites W1974167857 @default.
- W2808553092 cites W1983587751 @default.
- W2808553092 cites W1990386050 @default.
- W2808553092 cites W2000327580 @default.
- W2808553092 cites W2006871036 @default.
- W2808553092 cites W2013344605 @default.
- W2808553092 cites W2021172314 @default.
- W2808553092 cites W2029497643 @default.
- W2808553092 cites W2033314289 @default.
- W2808553092 cites W2056195142 @default.
- W2808553092 cites W2059363555 @default.
- W2808553092 cites W2064609355 @default.
- W2808553092 cites W2065850138 @default.
- W2808553092 cites W2067419747 @default.
- W2808553092 cites W2078963273 @default.
- W2808553092 cites W2102650381 @default.
- W2808553092 cites W2113452945 @default.
- W2808553092 cites W2115062578 @default.
- W2808553092 cites W2115593774 @default.
- W2808553092 cites W2116875654 @default.
- W2808553092 cites W2135830745 @default.
- W2808553092 cites W2154568002 @default.
- W2808553092 cites W2155127143 @default.
- W2808553092 cites W2163225870 @default.
- W2808553092 cites W2167292948 @default.
- W2808553092 cites W2167415368 @default.
- W2808553092 cites W2419208337 @default.
- W2808553092 cites W2555947024 @default.
- W2808553092 cites W2565873626 @default.
- W2808553092 cites W2587857225 @default.
- W2808553092 cites W2613260012 @default.
- W2808553092 cites W4317926777 @default.
- W2808553092 doi "https://doi.org/10.1097/sap.0000000000001519" @default.
- W2808553092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29905606" @default.
- W2808553092 hasPublicationYear "2018" @default.
- W2808553092 type Work @default.
- W2808553092 sameAs 2808553092 @default.
- W2808553092 citedByCount "4" @default.
- W2808553092 countsByYear W28085530922018 @default.
- W2808553092 countsByYear W28085530922022 @default.
- W2808553092 crossrefType "journal-article" @default.
- W2808553092 hasAuthorship W2808553092A5005889866 @default.
- W2808553092 hasAuthorship W2808553092A5009734430 @default.
- W2808553092 hasAuthorship W2808553092A5021383531 @default.
- W2808553092 hasAuthorship W2808553092A5023070517 @default.
- W2808553092 hasAuthorship W2808553092A5027001679 @default.
- W2808553092 hasAuthorship W2808553092A5040751092 @default.
- W2808553092 hasAuthorship W2808553092A5049109639 @default.
- W2808553092 hasAuthorship W2808553092A5051941269 @default.
- W2808553092 hasAuthorship W2808553092A5055151897 @default.
- W2808553092 hasAuthorship W2808553092A5064198617 @default.
- W2808553092 hasAuthorship W2808553092A5072032369 @default.
- W2808553092 hasConcept C104317684 @default.
- W2808553092 hasConcept C141071460 @default.
- W2808553092 hasConcept C150903083 @default.
- W2808553092 hasConcept C185592680 @default.
- W2808553092 hasConcept C207001950 @default.
- W2808553092 hasConcept C2776202225 @default.
- W2808553092 hasConcept C2776262904 @default.
- W2808553092 hasConcept C2776694085 @default.
- W2808553092 hasConcept C2777292972 @default.
- W2808553092 hasConcept C2778305200 @default.
- W2808553092 hasConcept C2780269544 @default.
- W2808553092 hasConcept C55493867 @default.
- W2808553092 hasConcept C64927066 @default.
- W2808553092 hasConcept C71924100 @default.
- W2808553092 hasConcept C86803240 @default.
- W2808553092 hasConcept C98274493 @default.
- W2808553092 hasConceptScore W2808553092C104317684 @default.
- W2808553092 hasConceptScore W2808553092C141071460 @default.
- W2808553092 hasConceptScore W2808553092C150903083 @default.
- W2808553092 hasConceptScore W2808553092C185592680 @default.
- W2808553092 hasConceptScore W2808553092C207001950 @default.
- W2808553092 hasConceptScore W2808553092C2776202225 @default.
- W2808553092 hasConceptScore W2808553092C2776262904 @default.
- W2808553092 hasConceptScore W2808553092C2776694085 @default.
- W2808553092 hasConceptScore W2808553092C2777292972 @default.
- W2808553092 hasConceptScore W2808553092C2778305200 @default.
- W2808553092 hasConceptScore W2808553092C2780269544 @default.
- W2808553092 hasConceptScore W2808553092C55493867 @default.